Al‐Hassan M. Mustafa

Synthesis, Molecular Docking and Biological Characterization of Pyrazine Linked 2-Aminobenzamides as New Class I Selective Histone Deacetylase (HDAC) Inhibitors with Anti-Leukemic Activity

Hany S. Ibrahim, Mohamed Abdelsalam, Yanira Zeyn et al. · International Journal of Molecular Sciences · 2021 · 50 citations · Full text

Medicinal Chemistry, Biochemistry, Specific Hdaci +15

HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1

Mandy Beyer, A Romański, Al‐Hassan M. Mustafa et al. · Cancers · 2019 · 33 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Cell Proliferation +18

Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells

Anke Rauch, Annemarie Carlstedt, Claudia Emmerich et al. · Oncotarget · 2018 · 29 citations · Full text

Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3

Vanessa Wachholz, Al‐Hassan M. Mustafa, Yanira Zeyn et al. · Archives of Toxicology · 2021 · 26 citations · Full text

Identification of a highly efficient dual type I/II FMS-like tyrosine kinase inhibitor that disrupts the growth of leukemic cells

Mandy Beyer, Sven J. Henninger, Patricia S. Haehnel et al. · Cell chemical biology · 2021 · 23 citations

Novel Therapy, Leukemic Cells, Receptor Tyrosine Kinase +9